Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients. [electronic resource]
Producer: 20190715Description: 251 p. digitalISSN:- 1479-5876
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cell Line, Tumor
- Colorectal Neoplasms -- drug therapy
- Female
- Fluorouracil -- therapeutic use
- Follow-Up Studies
- Humans
- Leucovorin -- therapeutic use
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Metastasis
- Neoplastic Cells, Circulating -- pathology
- Organoplatinum Compounds -- therapeutic use
- Prognosis
- Proportional Hazards Models
- Receptors, Vascular Endothelial Growth Factor -- metabolism
- Reference Standards
- Response Evaluation Criteria in Solid Tumors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.